More DMARDs can reduce glucocorticoids in LORA

Although glucocorticoids have no influence on the course of the disease, they are effective agents against symptomatic pain and inflammation in rheumatoid arthritis (RA). Patients with late onset RA (LORA) in particular are often on long-term glucocorticoids, contrary to the guidelines. They are more susceptible to the negative effects. Reducing the use of GK is advisable – but easier said than done in practice.